Trump’s 200% Pharma Tariff? Timeline, Impacts, and What Comes Next | Making Medicine Podcast

In this week’s episode, John Stanford breaks down the evolving story of President Trump’s aggressive tariff strategy—focusing on a potential 200% tariff on pharmaceuticals. From a historical look at Trump’s decades-long affinity for tariffs to the current Section 232 investigation into pharmaceutical imports, we explore what these actions could mean for national security, drug prices, and innovation. Could this policy lead to onshoring more drug manufacturing—or just higher prices for patients? And what exactly is “Liberation Day”? What are your thoughts on a 200% pharma tariff?Is this a smart way to strengthen domestic manufacturing—or a policy that could backfire? 📱If you're new to the Making Medicine Podcast, we're happy you're here! Follow us for more:https://x.com/MakingMedPodhttps://www.instagram.com/makingmedicinepod/https://www.linkedin.com/showcase/making-medicine-podcast/about/?viewAsMember=true Timestamps:0:00 Welcome and Overview0:33 Why Tariffs? A Trump Trade Philosophy1:32 Trump’s History with Tariffs2:32 The 2025 Tariff Timeline3:59 Liberation Day and the Global Tariff Shock4:53 August 1st Deadline and Market Reaction5:27 Trump Floats 200% Pharmaceutical Tariff6:03 Section 232 Investigation Explained6:56 Incubate’s Response and Global Supply Chain Concerns7:50 National Security, APIs, and the Commerce Department8:56 Trump’s Endgame: Manufacturing Medicines at Home9:44 What the Industry Should Expect10:26 Why We’re Still in the Dark10:50 Next Week’s Preview: The Press Pass Segment